ArticleRMD open2023

Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritis.

Esther Beckers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.